{"id":"W2095031513","doi":"10.1007/s00280-012-1889-8","title":"A phase I study of bevacizumab, everolimus and panitumumab in advanced solid tumors","year":2012,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":44,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"National Cancer Institute; Institut national de la recherche scientifique; Amgen","keywords":"Everolimus; Bevacizumab; Panitumumab; Solid tumor; Medicine; Oncology; Internal medicine; Cancer research; Chemotherapy; Cancer; Colorectal cancer; KRAS","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001647523,0.00168787,0.002889266,0.0007270739,0.0006490651,0.001205469,0.001109942,0.001482134,0.002635059],"category_scores_gemma":[0.0007603173,0.0009114085,0.001610153,0.0007156302,0.001308276,0.001081576,0.0004022559,0.003933611,0.0007066898],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001147391,"about_ca_system_score_gemma":0.002051959,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002317467,"about_ca_topic_score_gemma":0.005516816,"domain_scores_codex":[0.9994816,0.0002128493,0.00001989992,0.00009616154,0.00004487764,0.0001445587],"domain_scores_gemma":[0.9992185,0.0001036643,0.00009296487,0.00007946855,0.00004353799,0.0004619246],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6963559,0.119048,0.004162179,0.0006829785,0.001674255,0.0003261891,0.000356812,0.004939765,0.07765629,0.0006002925,0.00530611,0.08889119],"study_design_scores_gemma":[0.5244027,0.4560075,0.006600496,0.00002453427,0.000605223,0.0002772981,0.00007373135,0.001050868,0.007125753,0.0002623847,0.003531681,0.00003785532],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9913687,0.002742351,0.0006687996,0.0006377115,0.0002034961,0.001691627,0.000986354,0.00009032549,0.001610676],"genre_scores_gemma":[0.9856454,0.003307555,0.002167193,0.0007642637,0.0001987783,0.002130346,0.002541235,0.00006265082,0.003182668],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002889266,"threshold_uncertainty_score":0.008815169,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01769403803337643,"score_gpt":0.3676464043998438,"score_spread":0.3499523663664674,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}